Compound ID	CDAMM02975
Common name	Hydrangenoside E
IUPAC name	methyl 3-ethenyl-4-[[4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]oxan-2-yl]methyl]-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carboxylate
Molecular formula	C₂₉H₄₀O₁₂

Experimental data

Retention time	10.36
Adduct	[M+H]+
Actual mz	581.26
Theoretical mz	581.259
Error	0.9
Ionizaton mode	Positive
Instrument type	LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score	6.6506

Identifiers and class information

Inchi key	SYCAAOWPYJBQKF-UHFFFAOYNA-N
Smiles	O=C(OC)C1=COC(OC2OC(CO)C(O)C(O)C2O)C(C=C)C1CC3OC(CCC4=CC=C(O)C=C4)CC(O)C3
Superclass	Lipids and lipid-like molecules
Class	Prenol lipids

Plant source

Clitoria ternatea L.

External sources

HMDB ID
KNApSAcK ID	C00044812
FooDB ID
DrugBank ID
ChEBI ID
Pubchem Compound ID	73808150
PlantCyc ID
UNPD ID	UNPD137816
Coconut ID	CNP0261877
LipidMAPS ID
NANPDB ID

Pharmacokinetic properties

Number of descriptor values(#stars)	3
Number of non-conjugated amine groups (#amine)	0
Number of amidine and guanidine groups (#amidine)	0
Number of carboxylic acid groups (#acid)	0
Number of non-conjugated amide groups (#amide)	0
Number of rotatable bonds (#rotor)	16
Number of reactive functional groups (#rtvFG)	3
Predicted central nervous system activity (CNS)	-2
Molecular weight (mol_MW)	580.628
Computed dipole moment(dipole)	9.068
Total solvent accessible surface area (SASA)	769.964
Hydrophobic component of SASA (FOSA)	353.688
Hydrophilic component of SASA (FISA)	276.426
Pie component of the SASA (PISA)	139.85
Weakly polar component of the SASA (WPSA)	0
Total solvent accesible volume (volume)	1588.78
Number of hydrogen bond donors (donorHB)	6
Number of hydrogen bond acceptors (accptHB)	18.05
Free energy of solvation of dipole (dip^2/V)	0.0517541
Index of cohesive interaction in solids (ACxDN^.5/SA)	0.0574225
Globularity descriptor (glob)	0.855204
Predicted polarizability in cubic angstroms (QPpolrz)	48.491
Predicted hexadecane/gas partition coefficient (QPlogPC16)	17.013
Predicted octanol/gas partition coefficient (QPlogPoct)	35.812
Predicted water/gas partition coefficient (QPlogPw)	27.441
Predicted octanol/water partition coefficient (QPlogPo/w)	-0.132
Predicted aqueous solubility (QPlogS)	-2.083
Conformation-independent predicted aqueous solubility (CIQPlogS)	-4.26
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)	-4.542
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)	23.689
Predicted brain/blood partition coefficient (QPlogBB)	-2.921
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)	8.658
Predicted skin permeability, log Kp (QPlogKp)	-4.585
PM3 calculated ionization potential (IP(ev))	9.389
PM3 calculated electron affinity (EA(eV))	0.059
Number of likely metabolic reactions (#metab)	10
Prediction of binding to human serum albumin (QPlogKhsa)	-0.895
Predicted qualitative human oral absorption (HumanOralAbsorption)	1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)	11.901
Solvent-accessible surface area of fluorine atoms (SAFluorine)	0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)	0
Van der Waals surface area (PSA)	189.774
Number of nitrogen and oxygen atoms (#NandO)	12
Number of violations of Lipinski’s rule of five (RuleOfFive)	3
Number of violations of Jorgensen’s rule of three (RuleOfThree)	1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID	Gene name	Target name	TTD_ID	Prediction source
Q9ULX7	CA14	Carbonic anhydrase XIV	T31992	SEA
P15692	VEGFA	Vascular endothelial growth factor A	T20761	SEA
P05230	FGF1	Acidic fibroblast growth factor	T18639	SEA
P09038	FGF2	Basic fibroblast growth factor	T31621	SEA
P60568	IL2	Interleukin-2	T61698	SEA
P17931	LGALS3	Galectin-3	T72038	SEA
P04746	AMY2A	Pancreatic alpha-amylase	T86918	SEA
P14679	TYR	Tyrosinase	T97035	SEA

Target associated diseases

TTD_ID	Disease_ID	Disease name	ICD_11	Uniprot ID	Gene names
T31992	DI0046	Bacterial infection	[ICD-11: 1A00-1C4Z]	Q9ULX7	CA14
T31992	DI0204	Inborn metabolism deficiency	[ICD-11: 5C50-5C59]	Q9ULX7	CA14
T20761	DI0095	Colorectal cancer	[ICD-11: 2B91]	P15692	VEGFA
T20761	DI0365	Retinopathy	[ICD-11: 9B71]	P15692	VEGFA
T20761	DI0430	Vascular system developmental anomaly	[ICD-11: LA90]	P15692	VEGFA
T18639	DI0081	Chronic arterial occlusive disease	[ICD-11: BD4Z]	P05230	FGF1
T18639	DI0102	Coronary atherosclerosis	[ICD-11: BA52]	P05230	FGF1
T31621	DI0005	Acne vulgaris	[ICD-11: ED80]	P09038	FGF2
T61698	DI0275	Multiple sclerosis	[ICD-11: 8A40]	P60568	IL2
T61698	DI0361	Renal cell carcinoma	[ICD-11: 2C90]	P60568	IL2
T72038	DI0190	Hypertension	[ICD-11: BA00-BA04]	P17931	LGALS3
T72038	DI0199	Idiopathic interstitial pneumonitis	[ICD-11: CB03]	P17931	LGALS3
T72038	DI0252	Melanoma	[ICD-11: 2C30]	P17931	LGALS3
T72038	DI0302	Non-alcoholic fatty liver disease	[ICD-11: DB92]	P17931	LGALS3
T72038	DI0351	Psoriasis	[ICD-11: EA90]	P17931	LGALS3
T86918	DI0110	Cystic fibrosis	[ICD-11: CA25]	P04746	AMY2A
T86918	DI0328	Pancreatic malfunction	[ICD-11: DC30-DC3Z]	P04746	AMY2A
T97035	DI0007	Acquired hypermelanosis	[ICD-11: ED60]	P14679	TYR
T97035	DI0008	Acquired hypomelanotic disorder	[ICD-11: ED63]	P14679	TYR